3.92 USD
+0.72 (+22.5%)
3.22 USD
-0.7 (-17.86%)
RSLS gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 186 industry peers in the Health Care Equipment & Supplies industry. The financial health of RSLS is average, but there are quite some concerns on its profitability. RSLS has a expensive valuation and it also scores bad on growth.
1. Profitability
1.1 Basic Checks
- In the past year RSLS has reported negative net income.
- RSLS had a negative operating cash flow in the past year.
- In the past 5 years RSLS always reported negative net income.
- In the past 5 years RSLS always reported negative operating cash flow.
1.2 Ratios
- RSLS's Return On Assets of -53.42% is on the low side compared to the rest of the industry. RSLS is outperformed by 66.84% of its industry peers.
- Looking at the Return On Equity, with a value of -281.54%, RSLS is doing worse than 77.01% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -53.42% | ||
| ROE | -281.54% | ||
| ROIC | N/A |
ROA(3y)-223.45%
ROA(5y)-181.34%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- With a decent Gross Margin value of 63.74%, RSLS is doing good in the industry, outperforming 65.24% of the companies in the same industry.
- In the last couple of years the Gross Margin of RSLS has grown nicely.
- RSLS does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 63.74% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.95%
GM growth 5Y44.4%
2. Health
2.1 Basic Checks
- RSLS does not have a ROIC to compare to the WACC, probably because it is not profitable.
- RSLS has more shares outstanding than it did 1 year ago.
- The number of shares outstanding for RSLS has been increased compared to 5 years ago.
- Compared to 1 year ago, RSLS has a worse debt to assets ratio.
2.2 Solvency
- Based on the Altman-Z score of -130.89, we must say that RSLS is in the distress zone and has some risk of bankruptcy.
- RSLS's Altman-Z score of -130.89 is on the low side compared to the rest of the industry. RSLS is outperformed by 96.26% of its industry peers.
- RSLS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -130.89 |
ROIC/WACCN/A
WACC8.88%
2.3 Liquidity
- RSLS has a Current Ratio of 1.53. This is a normal value and indicates that RSLS is financially healthy and should not expect problems in meeting its short term obligations.
- Looking at the Current ratio, with a value of 1.53, RSLS is doing worse than 73.80% of the companies in the same industry.
- A Quick Ratio of 0.91 indicates that RSLS may have some problems paying its short term obligations.
- Looking at the Quick ratio, with a value of 0.91, RSLS is doing worse than 82.35% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.53 | ||
| Quick Ratio | 0.91 |
3. Growth
3.1 Past
- The Earnings Per Share has grown by an impressive 93.64% over the past year.
- The Revenue for RSLS has decreased by -13.93% in the past year. This is quite bad
- RSLS shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 19.54% yearly.
EPS 1Y (TTM)93.64%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%114%
Revenue 1Y (TTM)-13.93%
Revenue growth 3Y-16.19%
Revenue growth 5Y19.54%
Sales Q2Q%-42.75%
3.2 Future
- No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y20%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year20%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
- RSLS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
- Also next year RSLS is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
- No dividends for RSLS!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
RESHAPE LIFESCIENCES INC / RSLS FAQ
What is the fundamental rating for RSLS stock?
ChartMill assigns a fundamental rating of 2 / 10 to RSLS.
What is the valuation status of RESHAPE LIFESCIENCES INC (RSLS) stock?
ChartMill assigns a valuation rating of 0 / 10 to RESHAPE LIFESCIENCES INC (RSLS). This can be considered as Overvalued.
What is the profitability of RSLS stock?
RESHAPE LIFESCIENCES INC (RSLS) has a profitability rating of 1 / 10.
What is the expected EPS growth for RESHAPE LIFESCIENCES INC (RSLS) stock?
The Earnings per Share (EPS) of RESHAPE LIFESCIENCES INC (RSLS) is expected to grow by 20% in the next year.